Strs Ohio Sells 58,382 Shares of DuPont de Nemours, Inc. $DD

Key Points

• Strs Ohio reduced its DuPont stake by 7.9%, selling 58,382 shares in Q4 and finishing the period with 677,627 shares worth about $27.24 million (≈0.16% of the company).
• DuPont declared a quarterly dividend of $0.20 per share (annualized $0.80, ~1.7% yield), with record/ex-dividend date on May 15 and payment on May 29.
• Recent results and outlook: DuPont reported $0.46 EPS vs. $0.43 expected and flat revenue year-over-year, guided FY2026 EPS to $2.25–$2.30, and carries an average analyst price target of $54.57 with a "Moderate Buy" consensus.

Strs Ohio cut its holdings in DuPont de Nemours, Inc. (NYSE:DD - Free Report) by 7.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 677,627 shares of the basic materials company's stock after selling 58,382 shares during the period. Strs Ohio owned approximately 0.16% of DuPont de Nemours worth $27,241,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of DD. Salomon & Ludwin LLC boosted its holdings in DuPont de Nemours by 186.5% in the third quarter. Salomon & Ludwin LLC now owns 318 shares of the basic materials company's stock worth $25,000 after purchasing an additional 207 shares in the last quarter. Palisade Asset Management LLC bought a new stake in DuPont de Nemours in the third quarter worth $26,000. Financial Life Planners bought a new stake in DuPont de Nemours in the third quarter worth $27,000. Imprint Wealth LLC bought a new stake in DuPont de Nemours in the third quarter worth $27,000. Finally, Miller Global Investments LLC bought a new stake in DuPont de Nemours in the fourth quarter worth $28,000. 73.96% of the stock is currently owned by institutional investors.

DuPont de Nemours Stock Up 1.6%

Shares of DD opened at $46.38 on Friday. The company has a 50-day simple moving average of $46.49 and a 200-day simple moving average of $42.95. The firm has a market capitalization of $19.01 billion, a P/E ratio of -24.93, a P/E/G ratio of 1.60 and a beta of 1.03. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.91 and a current ratio of 2.42. DuPont de Nemours, Inc. has a 52 week low of $26.82 and a 52 week high of $52.66.

DuPont de Nemours (NYSE:DD - Get Free Report) last announced its quarterly earnings data on Tuesday, February 10th. The basic materials company reported $0.46 EPS for the quarter, beating analysts' consensus estimates of $0.43 by $0.03. The business had revenue of ($1,871.00) million during the quarter, compared to analyst estimates of $1.69 billion. DuPont de Nemours had a negative net margin of 7.03% and a positive return on equity of 7.37%. The firm's revenue for the quarter was up .2% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.13 earnings per share. DuPont de Nemours has set its FY 2026 guidance at 2.250-2.300 EPS and its Q1 2026 guidance at 0.480-0.480 EPS. On average, equities research analysts expect that DuPont de Nemours, Inc. will post 2.27 earnings per share for the current year.

DuPont de Nemours Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 29th. Stockholders of record on Friday, May 15th will be given a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, May 15th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.7%. DuPont de Nemours's dividend payout ratio is currently -43.01%.

Wall Street Analysts Forecast Growth

DD has been the subject of a number of recent research reports. UBS Group upped their price objective on shares of DuPont de Nemours from $49.00 to $56.00 and gave the stock a "buy" rating in a report on Wednesday, February 11th. BMO Capital Markets boosted their target price on shares of DuPont de Nemours from $25.10 to $60.00 and gave the stock an "outperform" rating in a research report on Monday, April 13th. KeyCorp boosted their target price on shares of DuPont de Nemours from $51.00 to $57.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 11th. Citigroup cut their target price on shares of DuPont de Nemours from $59.00 to $56.00 and set a "buy" rating for the company in a research report on Monday, April 13th. Finally, Morgan Stanley boosted their target price on shares of DuPont de Nemours from $44.00 to $52.00 and gave the stock an "equal weight" rating in a research report on Tuesday, April 28th. Twelve research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $54.57.

DuPont de Nemours Company Profile

DuPont de Nemours NYSE: DD is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont's operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.

Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont de Nemours, Inc. (NYSE:DD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.